CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer ’s disease

Despite its identification as a key checkpoint regulator of microglial activation in Alzheimer ’s disease, the overarching role of CX3CR1 signaling in modulating mechanisms of Aβ driven neurodegeneration, inclu...

Source: Molecular Neurodegeneration - June 28, 2022 Category: Neurology Authors: Shweta S. Puntambekar, Miguel Moutinho, Peter Bor-Chian Lin, Vaishnavi Jadhav, Danika Tumbleson-Brink, Ananya Balaji, Martin Alvarado Benito, Guixiang Xu, Adrian Oblak, Cristian A. Lasagna-Reeves, Gary E. Landreth and Bruce T. Lamb Tags: Research article Source Type: research